Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001562180-19-002478

President, Diagnostics & Genom acquired 1,667 shares (option exercise)

  • President, Diagnostics & Genom gave up 844 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kelderman Kim President, Diagnostics & Genom 2019-05-01 Option exercise +1,667 $202.13 $336,951 1,667 D
Kelderman Kim President, Diagnostics & Genom 2019-05-01 Shares withheld for taxes −844 $202.13 $170,598 823 D
Derivatives
Kelderman Kim President, Diagnostics & Genom 2019-05-01 Option exercise · Restricted Stock −1,667 0 D
Loading xslF345X03/primarydocument.xml…